ライフサイエンスコーパス: were available for

1 the 206 participants (mean [SD] age, 31.3 [5.6] years), 166 were available for analysis at 24 months (retention, 80.5%).

2 A total of 407 patients received the intended treatment and were available for primary outcome measurement.

3 puted tomography (CT) and a CT angiography (CTA) at arrival were available for review.

4 Data on BMI were available for 15 237 participants.

5 etry and atopy at age of 8 years, and potential confounders were available for 1608 participants of the PIAMA birth cohor

6 Data to estimate NSP coverage were available for 57 countries, and for 60 countries to esti

7 Data were available for 1 238 188 patients, covering 64 National H

8 Results Biomarker data were available for 340 patients.

9 Complete data were available for 3152 participants (aged 15 years; 53% boys

10 proximity to sulfur application and relevant covariate data were available for 237 and 205 children for whom we had sympt

11 After crossover, data were available for 22 itMSC patients.

12 In total, exposure data were available for 296 subjects, 188 of whom had complete spi

13 Although limited data were available for low-income and middle-income countries, ou

14 articipants, all risk factor measurements and location data were available for 28 887 (96%).

15 Results Of 4,058 unique individual plans, network data were available for 3,637 (90%); hospital information was avai

16 Week 12 outcome data were available for 132 patients who initiated with mesalazine

17 Outcome data were available for 248 plans (68% of plans operating prior to

18 The 5-year outcome data were available for spirometry (n = 697), cough (n = 722), and

19 Postintervention data were available for 8271 women and 5371 children younger than

20 Sequencing data were available for 254 (56%) of the NeoALTTO participants (me

21 Genome-wide association study data were available for 4609 individuals with ADHD, 9650 individua

22 nge] age, 62 [52-72] years), complete 1-year follow-up data were available for 2164 (98.5%).

23 mediating role of maternal concern about child weight.Data were available for 4689 mother-child dyads participating in G

24 rative synthesis of the data in each report, and where data were available for the years before and after a ban, we poole

25 a on cognitive performance tests at the 4-y re-examinations were available for 480 men.

26 tre Discovery Cohort and, after quality control, 228 exomes were available for analyses.

27 tations in both driver and selected nondriver myeloid genes were available for all patients.

28 xtent during the dough stage that insufficient thiol groups were available for forming dough layer interconnections durin

29 ution for which both standard-dose and synthetic mammograms were available for analysis were retrospectively analyzed.

30 y published report respiratory muscle strength measurements were available for 78 patients with ALS.

31 Data on the primary outcome were available for 4274 of 4458 infants (96%) born at the 11

32 t Danish and Swedish surgical departments, and 112 patients were available for analysis.

33 ts were available for correlation analysis, and 12 patients were available for assessment of tumor overlap.

34 One hundred ninety-seven patients were available for analysis because 3 patients withdrew conse

35 Seventeen patients were available for correlation analysis, and 12 patients were

36 Three hundred eighty-six patients were available for analysis in the intention-to-treat and 257

37 hy volunteers because no pharmacokinetic data in recipients were available for all products.

38 Complete records were available for 323 women; 54 women met criteria for P-SCA

39 f laboratory tests for Zika virus and brain imaging results were available for 79 (87%) cases; within these cases, ten we

40 Of the 503 study participants, MSI results were available for 303 patients (283 with microsatellite stab

41 f 5,126 patients enrolled, RT-PCR and serology test results were available for 2,023, including 1,087 children below the

42 Paired tumor and plasma samples were available for most patients (24 of 30).

43 At 6 months, data for the Oxford Shoulder Score were available for 90 patients assigned to decompression, 94

44 subjects who participated, complete, good-quality data sets were available for 100: 48 currently depressed older adults a

45 from the UK Biobank, in whom 77 of the 100 suggestive SNVs were available for association analysis with systolic BP or d

46 Urine specimens were available for 260 women with 85.4% from the Americas and

47 Four large database studies were available for review, including 2 published after the "2

48 tern series using domestic corneas in which fresher tissues were available for transplantation.

49 ing depth [PD], vertical clinical attachment level [CAL-V]) were available for patients at baseline and 12 months after s

50 At long-term follow-up (results of which were available for 63% of the patients), the most common nota